Organization Profile

You just read:

Transition Therapeutics Announces Results of Clinical Study of ELND005 in Agitation and Aggression in Patients with Alzheimer's Disease

News provided by

Transition Therapeutics Inc.

Jun 24, 2015, 06:01 ET